
Best of the Week: September 5 – September 11, 2025
Key Takeaways
- Nebraska's new cannabis regulations face backlash for contradicting voter-approved access, highlighting tensions between regulatory bodies and public demand.
- U.S. Congress members oppose cannabis rescheduling to Schedule III, citing risks to children and potential tax benefits for illegal entities.
Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.
Let’s dive into the top stories shaping the conversation this week. Summaries of each article are listed below.
1. Voters' Will vs. New Rules: The Battle for Medical Cannabis in Nebraska
Nebraska Medical Cannabis Commission members announced that they had approved more regulations that would limit a patients’ access to obtaining medical cannabis products. These new regulations will need to be approved by Nebraska Governor Jim Pillen.
“
In 2024, voters had approved to legalize medical cannabis through two ballot initiatives, supported by Nebraskan voters by two to one.
2. Congress Members Urge Attorney General to Reject Cannabis Rescheduling to Schedule III
Multiple members of Congress sent a
“We write to urge you to reject the Biden Administration’s corrupt and flawed recommendation to reclassify marijuana as a Schedule III drug,” the letter begins. “Rescheduling marijuana would send a message to kids that marijuana is not harmful and allow Big Marijuana and foreign drug cartels to get billions per year in federal tax breaks.”
The main arguments in the letter focus on:
- The CSA system of scheduling.
- The potential tax breaks for illegal businesses.
- The risk of harm to children.
3. Thailand's Crossroad: Will New Leadership Spark Cannabis Legalization?
The cannabis industry in Thailand is constantly shifting. In June 2025, the
On September 5, 2025,
The previous Prime Minister was Paetongtarn Shinawatra, who was removed from political office via a court ruling.
4. Medical Cannabis Research Update: Cancer, Wound Healing, ALS, Alzheimer’s, and Terpenes
Can cannabis help cancer patients live longer, speed wound healing, or ease Alzheimer’s symptoms? Dr. Dustin Sulak explores new research surrounding these questions in the September 2025 webinar. Dr. Sulak, an osteopathic general practitioner, founder of Healer, a cannabis education and product resource, presented the latest installment of this monthly webinar series discussing potential benefits for cancer, THC and wound healing research, cannabinoids for amyotrophic lateral sclerosis (ALS) treatment, nabiximols for Alzheimer’s agitation, and alpha-pinene and THC effects on memory.
5. Test Your Knowledge: What's Driving the Cannabis Pricing Crisis?
The cannabis industry is currently in a state of flux, experiencing significant wholesale price volatility and regional disparities that are expected to remain. This instability is driven by a complex interplay of market forces, including a patchwork of state-specific regulations, chronic oversupply in mature markets, and limited retail access in emerging states.
Our most recent Cultivation Classroom explains the trends shaping the 2025 cannabis market, discussing shrinking margins, increased competition, regional disparities, and how companies can adapt and thrive in the evolving industry.
Newsletter
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.